Improving the Quality of Care for Asthma Patients at Risk of Exacerbations

NANot yet recruitingINTERVENTIONAL
Enrollment

4,100

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

April 30, 2030

Study Completion Date

May 31, 2030

Conditions
Moderate-to-Severe Asthma
Interventions
DRUG

PARTICS using a single ICS add on

Participants randomized to PARTICS who use a nebulizer less than once a week are instructed to use the study prescribed ICS each time they use their rescue inhaler and take 5 puffs of the newly prescribed ICS after each rescue nebulizer use.

DRUG

MART

Participants are instructed to use prescribed study ICS/LABA for maintenance and as needed for rescue.

Trial Locations (6)

19122

University of Pennsylvania, Philadelphia

27705

Duke University, Durham

53792

University of Wisconsin Madison, Madison

63110

Washington University, St Louis

06510

Yale University, New Haven

02115

Brigham and Womens Hospital, Boston

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

lead

Brigham and Women's Hospital

OTHER

NCT06596512 - Improving the Quality of Care for Asthma Patients at Risk of Exacerbations | Biotech Hunter | Biotech Hunter